Clinical Trial Update: MagDI Canada Study [NA]

View source ↗

Summary

The MagDI Canada Study, sponsored by GT Metabolic Solutions, Inc., is currently recruiting participants for obesity and type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: GT Metabolic Solutions, Inc. | Conditions: Obesity, Type 2 Diabetes | NA | Status: RECRUITING